Fertility Blog

At a glance → A coalition of 56 patient and professional organizations announced on May 12, 2026 that polycystic ovary syndrome will now be called polyendocrine metabolic ovarian syndrome, abbreviated PMOS → The decision followed a 14-year consensus process led by researchers at Monash University, with input from more than 22,000 patients and health professionals across six continents → Adoption will be gradual, with both names appearing in medical records, lab reports, and patient materials until PMOS becomes the standard term → Diagnostic criteria and treatment protocols are not affected by the renaming; fertility care for PMOS uses the same clinical approach as PCOS care In this article, you will find a plain-language breakdown of the PCOS name change, why your diagnosis and care will stay the same, and what the shift could mean for fertility treatment and research, from a reproductive endocrinologist who specializes in the condition.

Last updated February 2026 The world of fertility can be overwhelming to navigate, and this holds especially true for many women of color. Harmful stereotypes, a lack of representation, and injustices in the healthcare system can cause women of color, especially Black women, to feel isolated from the conversation and discouraged from seeking fertility support.

PCOS isn’t one-size-fits-all, and your care shouldn’t be either. Whether you're looking to regulate your cycle, manage symptoms, or grow your family, finding a specialist who listens, explains, and creates a plan around your goals is essential. Here’s a step-by-step guide to help you find the right PCOS specialist near you and build the medical and emotional support team you deserve.

Over 10 million babies have been born with the help of IVF treatment since 1978, making it the most effective form of assisted reproductive technology (ART). But with so many unique factors that can affect your outcome, you may wonder, "What are my personal chances of success as a fertility patient?"

GLP-1 medications like Wegovy, Mounjaro, and Ozempic can all be used to treat type 2 diabetes, but they also show promise in treating symptoms of polycystic ovary syndrome (PCOS). Here's what you need to know.

Rebecca* is a wife, a mother, and a practicing Orthodox Jew. She is also among the 11 percent of women in the United States who have experienced infertility.